2-(4,4-Difluoropiperidin-1-yl)-6-methylpyrimidin-4-amine

Catalog No. :
ACJSYL417
CAS No. :
2446613-63-2
Molecular Formula :
C10H14F2N4
Molecular Weight :
228.25

IUPAC Name:2-(4,4-difluoropiperidin-1-yl)-6-methylpyrimidin-4-amine

2-(4,4-Difluoropiperidin-1-yl)-6-methylpyrimidin-4-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$109.00Login to see priceIn stockIn stock
250mg98%$184.00Login to see priceIn stockIn stock
1g98%$618.00Login to see priceIn stockInquiry
5g98%$1852.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4,4-Difluoropiperidin-1-yl)-6-methylpyrimidin-4-amine
IUPAC Name2-(4,4-difluoropiperidin-1-yl)-6-methylpyrimidin-4-amine
MDL No.-
Molecular FormulaC10H14F2N4
Molecular Weight228.25
SMILESNC1=NC(N2CCC(F)(F)CC2)=NC(C)=C1
InChI KeyNYOZABKUOYTRGW-UHFFFAOYSA-N
Synonym4-Pyrimidinamine, 2-(4,4-difluoro-1-piperidinyl)-6-methyl-;2-(4,4-difluoropiperidin-1-yl)-6-methylpyrimidin-4-amine;2-(4,4-Difluoro-1-piperidinyl)-6-methyl-4-pyrimidinamine
CAS No.2446613-63-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACJSYL417 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  4. Then
  5. ACJSYL417 route product structure diagram
    ACJSYL4172446613-63-2 In Stock
Inquiry

2. ACJSYL417 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJSYL417 route product structure diagram
    ACJSYL4172446613-63-2 In Stock
Inquiry

Comments (0)